Physician
Cardiology
Dr. David Kandzari, MD
|
|
Give Review
David Kandzari practices Cardiology. He studied medicine at Duke University School of Medicine. Duke University School of Medicine is one of the top medical schools in the US. Duke University School of Medicine has a rank of 8 in research and a 29 in primary care He received awards:"America's Top Doctors", "Atlanta Magazine: Top Doctors", "CMS Meaningful Use Stage 1 Certification", "Fellow (FACC)" and "Super Doctor". Dr. David Kandzari is a published doctor and has 97 publications published. The lastest was: 'Effect of Previous Failure on Subsequent Procedural Outcomes of Chronic Total Occlusion Percutaneous Coronary Intervention (from a Contemporary Multicenter Registry).' David Kandzari, MD accepts Medicare payments and is listed with Medicare.gov.
Publications
- Influence of Total Coronary Occlusion on Clinical Outcomes (from the Bypass Angioplasty Revascularization Investigation 2 DiabetesTrial).
- Effect of Previous Failure on Subsequent Procedural Outcomes of Chronic Total Occlusion Percutaneous Coronary Intervention (from a Contemporary Multicenter Registry).
- Stent Thrombosis in Drug-Eluting or Bare-Metal Stents in Patients Receiving Dual Antiplatelet Therapy.
- Impact of Lesion Placement on Efficacy and Safety of Catheter-Based Radiofrequency Renal Denervation.
- Application and outcomes of a hybrid approach to chronic total occlusion percutaneous Coronary intervention in a contemporary multicenter US registry.
- Antiplatelet therapy duration following bare metal or drug-eluting Coronary stents: the dual antiplatelet therapy randomized clinical trial.
- Temporal trends of fluoroscopy time and contrast utilization in Coronary chronic total occlusion revascularization: Insights from a multicenter united states registry.
- Transradial approach for Coronary chronic total occlusion interventions: Insights from a contemporary multicenter registry.
- Percutaneous Intervention of Circumflex Chronic Total Occlusions Is Associated With Worse Procedural Outcomes: Insights From a Multicentre US Registry.
- Twelve or 30 Months of Dual Antiplatelet Therapy after Drug-Eluting Stents.
- Predictors of blood pressure response in the SYMPLICITY HTN-3 trial.
- The Efficacy and Safety of the "Hybrid" Approach to Coronary Chronic Total Occlusions: Insights From a Contemporary Multicenter US Registry and Comparison With Prior S...
- Meta-analysis of the effect of renal denervation on blood pressure and pulse pressure in patients with resistant systemic Hypertension.
- A controlled trial of renal denervation for resistant Hypertension.
- Application of the "Hybrid Approach" to Chronic Total Occlusions in Patients With Previous Coronary Artery Bypass Graft Surgery (from a Contemporary Multicenter US Reg...
- The efficacy of "hybrid'' percutaneous Coronary intervention in chronic total occlusions caused by in-stent restenosis: Insights from a US multicenter registry.
- Long-term efficacy and safety of zotarolimus-eluting stent in patients with diabetes mellitus: Pooled 5-year results from the ENDEAVOR III and IV trials.
- Ready for a marathon, not a sprint: renal denervation therapy for treatment-resistant Hypertension.
- A novel application of contrast echocardiography to exclude active Coronary perforation bleeding in patients with pericardial effusion.
- The end of ENDEAVOR IV: the stent comparison trial's final follow-up.
- Procedural Outcomes of Revascularization of Chronic Total Occlusion of Native Coronary Arteries (from a Multicenter United States Registry).
- Development of a high-volume, multiple-operator program for percutaneous chronic total Coronary occlusion revascularization: procedural, clinical, and cost-utilization...
- Impact of prior Coronary artery bypass graft surgery on chronic total occlusion revascularisation: insights from a multicentre US registry.
- Final 5-Year Outcomes From the Endeavor Zotarolimus-Eluting Stent Clinical Trial Program: Comparison of Safety and Efficacy With First-Generation Drug-Eluting and Bare...
- The "Final" 5-Year Follow-Up From the ENDEAVOR IV Trial Comparing a Zotarolimus-Eluting Stent With a Paclitaxel-Eluting Stent.
- Procedural Effectiveness of a Novel 1.20?mm Diameter Angioplasty Catheter: Clinical and Angiographic Outcomes.
- Zotarolimus-eluting peripheral stents for the treatment of erectile dysfunction in subjects with suboptimal response to phosphodiesterase-5 inhibitors.
- The Kinetics of Integrilin Limited by Obesity: A multicenter randomized pharmacokinetic and pharmacodynamic clinical trial.
- Dual antiplatelet therapy duration and clinical outcomes following treatment with zotarolimus-eluting stents.
- Saphenous vein graft intervention.
- Percutaneous Coronary intervention of unprotected left main Coronary artery disease: Procedural strategies and technical considerations.
- Revascularization for Unprotected Left Main Coronary Artery Disease: An Evolution in Clinical Decision Making.
- Late-Term Clinical Outcomes With Zotarolimus- and Sirolimus-Eluting Stents 5-Year Follow-Up of the ENDEAVOR III (A Randomized Controlled Trial of the Medtronic Endeavo...
- Clinical outcomes following predilation with a novel 1.25-mm diameter angioplasty catheter.
- Use of drug-eluting stents for Chronic total occlusions: a systematic review and meta-analysis.
- Long-term clinical outcomes with zotarolimus-eluting versus bare-metal Coronary stents.
- Sex-specific outcomes following revascularization with zotarolimus-eluting stents: comparison of angiographic and late-term clinical results.
- Transradial versus transfemoral method of percutaneous Coronary revascularization for unprotected left main Coronary artery disease: comparison of procedural and late-...
- Pilot study of the antiplatelet effect of increased clopidogrel maintenance dosing and its relationship to CYP2C19 genotype in patients with high on-treatment reactivity.
- Unprotected left main Coronary disease and ST-segment elevation myocardial infarction: a contemporary review and argument for percutaneous Coronary intervention.
- A novel technique for ultra-low contrast administration during angiography or intervention.
- The transradial approach to percutaneous Coronary intervention: historical perspective, current concepts, and future directions.
- Comparison by meta-analysis of drug-eluting stents and bare metal stents for saphenous vein graft intervention.
- Identifying the "optimal" duration of dual antiplatelet therapy after drug-eluting stent revascularization.
- Percutaneous Coronary intervention in perspective: drug-eluting stents as a model for regulatory review.
- Clinical and angiographic outcomes in diabetics from the ENDEAVOR IV trial: randomized comparison of zotarolimus- and paclitaxel-eluting stents in patients with corona...
- Anaphylactoid reactions to radiocontrast agents: prevention and treatment in the cardiac catheterization laboratory.
- Import and export of interventional technique: something to declare at the border.
- Predictors of heightened platelet reactivity despite dual-antiplatelet therapy in patients undergoing percutaneous Coronary intervention.
- Evaluation of individualized clopidogrel therapy after drug-eluting stent implantation in patients with high residual platelet reactivity: design and rationale of the ...
- One-year outcomes from the TAXUS express stent versus cypher stent.
- A qualitative and quantitative angiographic analysis of stent fracture late following sirolimus-eluting stent implantation.
- Change we can believe in: the hyper-evolution of percutaneous Coronary intervention for unprotected left main disease with drug-eluting stents.
- Angiographic surrogate end points in drug-eluting stent trials: a systematic evaluation based on individual patient data from 11 randomized, controlled trials.
- Results from a phase II multicenter, double-blind placebo-controlled study of Del-1 (VLTS-589) for intermittent claudication in subjects with peripheral arterial Disease.
- Mechanism of luminal gain with plaque excision in atherosclerotic Coronary and peripheral arteries: assessment by histology and intravascular ultrasound.
- Clopidogrel use and long-term clinical outcomes after drug-eluting stent implantation.
- Overview of pharmacology and clinical trials program with the zotarolimus-eluting endeavor stent.
- Acute myocardial infarction: safety of cardiac MR imaging after percutaneous revascularization with stents.
- Temporal trends in target vessel revascularization in clinical practice: long-term outcomes following Coronary stenting from the Duke Database for Cardiovascular Disease.
- Comparison of long-term (seven year) outcomes among patients undergoing percutaneous Coronary revascularization with versus without stenting.
- Procedural and clinical outcomes with catheter-based plaque excision in critical limb ischemia.
- Future perspectives on antithrombin and antiplatelet therapies: novel antiplatelet and antithrombin therapies.
- Evolving antithrombotic treatment strategies for Acute ST-elevation myocardial infarction.
- Peripheral arterial Disease: an overview of endovascular therapies and contemporary treatment strategies.
- Anticoagulation in the cath lab: a contemporary approach. Introduction.
- Percutaneous recanalization of chronically occluded Coronary arteries: a consensus document: part II.
- Percutaneous recanalization of chronically occluded Coronary arteries: a consensus document: part I.
- Percutaneous recanalization of chronically occluded Coronary arteries: procedural techniques, devices, and results.
- Frequency, predictors, and outcomes of drug-eluting stent utilization in patients with high-risk non-ST-segment elevation Acute coronary syndromes.
- The thrill is gone: catheter-based exclusion of a posttraumatic arteriovenous fistula with a covered stent graft.
- Late thrombosis following treatment of in-stent restenosis with drug-eluting stents after discontinuation of antiplatelet therapy.
- Influence of clinical trial enrollment on the quality of care and outcomes for patients with non-ST-segment elevation Acute coronary syndromes.
- The challenges of chronic total Coronary occlusions: an old problem in a new perspective.
- Current concepts in the antithrombotic management of non-ST-elevation Acute coronary syndromes.
- Aspirin dose and six-month outcome after an Acute coronary syndrome.
- Feasibility of endovascular cooling as an adjunct to primary percutaneous Coronary intervention (results of the LOWTEMP pilot study).
- Improved clinical outcomes with abciximab therapy in Acute myocardial infarction: a systematic overview of randomized clinical trials.
- Catheter-based revascularization of the hepatic artery to treat Coronary steal from a gastroepiploic artery bypass graft.
- Reduction of myocardial ischemic injury following Coronary intervention (the MC-1 to Eliminate Necrosis and Damage trial).
- Meta-analysis of survival with platelet glycoprotein IIb/IIIa antagonists for percutaneous Coronary interventions.
- The VB-1 catheter: a novel catheter for peripheral arterial revascularization.
- Double negatives.
- Radiocontrast nephropathy: a time for affirmative action.
- The complementary use of glycoprotein IIb/IIIa inhibitors and drug-eluting stents in contemporary percutaneous Coronary intervention.
- Inflammation, platelets, and glycoprotein IIb/IIIa inhibitors.
- Seeking the optimal aspirin dose in Acute coronary syndromes.
- Integrating GP IIb/IIIa inhibition into treatment strategies for Acute ST-elevation myocardial infarction.
- IntraCoronary brachytherapy: time to sell short?
- Coronary artery stents: evaluating new designs for contemporary percutaneous intervention.
- TARGET versus GUSTO-IV: appropriate use of glycoprotein IIb/IIIa inhibitors in Acute coronary syndromes and percutaneous coronary intervention.
- Making positive out of negative trials.
- Experience with glycoprotein IIb/IIIa antagonists in patients with Acute coronary syndromes.
- An anomalous left Coronary artery originating from the pulmonary artery in a 72-year-old woman: diagnosis by color flow myocardial blush and Coronary arteriography.
- Highlights from the American Heart Association annual scientific sessions 2001: November 11 to 14, 2001.
- The bent stent.
Schools
Duke University School Of Medicine
Duke University Med Center
Johns Hopkins University School Med
Duke University
Procedures Preformed
- Automatic Implantable Cardioverter Defibrillator (ICD) Implantation
- Cardiac Catheterization (incl. Coronary Angiography)
- Cardiac Imaging
- Cardiac MRI (Magnetic Resonance Imaging) of Heart or Chest
- View All
Conditions Treated
- Aneurysm and Dissection of Heart
- Angina and Acute Coronary Syndrome
- Aortic Aneurysm
- Aortic Dissection
- View All
Doctors Specialties
- Cardiology
- Interventional Cardiology
Accepted Insurances
- Aetna HMO
- Aetna PPO
- Network P
- Cigna HMO
- Cigna PPO
- Flexcare
- Coventry Health Care
- Choice Care
- Medicare MCR
- NovaNet
- United Healthcare
- United Healthcare HMO
- United Healthcare POS
- United Healthcare PPO
Awards
- America's Top Doctors
- Atlanta Magazine: Top Doctors
- CMS Meaningful Use Stage 1 Certification
- Fellow (FACC)
- Super Doctor
Education
-
Duke University Hospital -
Johns Hopkins University -
Duke University School of Medicine
Hospital
-
Piedmont Hospital
Drug Facts
| NPI NUMBER | 1871677930 | |
| NPPES Provider LastName | KANDZARI | |
| NPPES Provider FirstName | DAVID | |
| NPPES Provider ZIPCode | 303091740 | |
| NPPES Provider State | GA | |
| Specialty Description | Cardiology | |
| Total Claim Count | 863.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1871677930 |
| Last Name Of The Provider | KANDZARI |
| First Name Of The Provider | DAVID |
| View All |
Similar Doctors
|
Dr. Stuart J. Toporoff, MD
 This Doctor is OpenDoctor Recommended.
|
|
Dr. Alexis C. Cutchins, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. M D. Byrd, MD |
|
Dr. Andrew C. Wickliffe, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Jeffrey L. Clark, MD |
|
|
Dr. Joseph S. Wilson Jr., MD |
|
|
Dr. William R. Smith Jr., MD |
|
|
Dr. Sasa Vukelic, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Sheila H. Heeke, NP |